CD28 and mature T-cell and NK-cell non-Hodgkin lymphoma: Further deep sequencing revealed a 30% frequency of CTLA-4/CD28 fusions in PTCL samples, suggesting that CTLA-4/CD28 gene fusions may be important in the pathogenesis of PTCL and represent a potential target for anti-CTLA-4 immunotherapy.